26‑Year MCT: Senior Pathological High Myopia Case
Many people believe myopia control is only for children and teenagers. Yet pathological high myopia remains a lifelong eye health challenge for adults.
This patient developed high myopia at an early age. As growing older, age‑related eye changes appeared, including hypertension and early cataract signs. For patients with pathological high myopia, the biggest risk comes from continuous retinal and macular damage, which may gradually affect long‑term vision.
During long‑term follow‑up, regular eye examinations and customized myopia management solutions were adopted. Over 26 years, macular atrophy progression was effectively slowed, and stable corrected vision was maintained.
| Monitoring Item | Pre‑wear Baseline | 10‑Year Follow‑Up | 26‑Year Review |
|---|---|---|---|
| Right Eye Uncorrected VA | 0.3 | 0.28 | 0.12 |
| Left Eye Uncorrected VA | 0.5 | 0.45 | 0.21 |
| MCT Corrected VA | 1.0 | Stable 1.0 | Stable 1.0 |
| Fundus Macular Status | Progressive atrophy | Atrophy slowed | Greatly stabilized |
| Corneal Condition | Normal | No scarring | Age‑related dry eyes only |
Key takeaways for high‑myopia adults
- High myopia monitoring does not stop after adulthood.
- Systemic conditions such as blood pressure will affect eye health.
- Long‑term regular eye screening helps catch early retinal changes before symptoms appear.
Even with lifelong high myopia, stable vision quality can be achieved with scientific monitoring and proper management.